Education
About Us
Working with TipRanks
Follow Us
Frontage Holdings Corp. (HK:1521)
:1521
1521 Stock Chart & Stats
HK$1.10
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.10
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.65 - HK$1.87
Previous CloseN/A
Volume454.00K
Average Volume (3M)468.13K
Market Cap
HK$2.26B
Enterprise ValueHK$2.99B
Total Cash (Recent Filing)HK$33.66M
Total Debt (Recent Filing)HK$137.70M
Price to Earnings (P/E)75.5
Beta1.12
Next Earnings
Mar 30, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding2,035,724,900
10 Day Avg. Volume431,000
30 Day Avg. Volume468,133
Financial Highlights & Ratios
PEG Ratio-6.36
Price to Book (P/B)1.39
Price to Sales (P/S)1.82
P/FCF Ratio31.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Frontage Holdings Corp. News
1521 FAQ
What was Frontage Holdings Corp.’s price range in the past 12 months?
Frontage Holdings Corp. lowest stock price was HK$0.65 and its highest was HK$1.87 in the past 12 months.
What is Frontage Holdings Corp.’s market cap?
Frontage Holdings Corp.’s market cap is HK$2.26B.
When is Frontage Holdings Corp.’s upcoming earnings report date?
Frontage Holdings Corp.’s upcoming earnings report date is Mar 30, 2026 which is in 148 days.
How were Frontage Holdings Corp.’s earnings last quarter?
Frontage Holdings Corp. released its earnings results on Aug 28, 2025. The company reported HK$0.031 earnings per share for the quarter, beating the consensus estimate of HK$0 by HK$0.031.
Is Frontage Holdings Corp. overvalued?
According to Wall Street analysts Frontage Holdings Corp.’s price is currently Overvalued.
Does Frontage Holdings Corp. pay dividends?
Frontage Holdings Corp. does not currently pay dividends.
What is Frontage Holdings Corp.’s EPS estimate?
Frontage Holdings Corp.’s EPS estimate is 0.
How many shares outstanding does Frontage Holdings Corp. have?
Frontage Holdings Corp. has 2,035,724,900 shares outstanding.
What happened to Frontage Holdings Corp.’s price movement after its last earnings report?
Frontage Holdings Corp. reported an EPS of HK$0.031 in its last earnings report, beating expectations of HK$0. Following the earnings report the stock price went down -0.725%.
Which hedge fund is a major shareholder of Frontage Holdings Corp.?
Currently, no hedge funds are holding shares in HK:1521
Frontage Holdings Corp. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
91.37%
12-Months-Change
Fundamentals
Return on Equity
1.13%
Trailing 12-Months
Asset Growth
-3.83%
Trailing 12-Months
Company Description
Frontage Holdings Corp.
Frontage Holdings Corp. (1521) is a contract research organization (CRO) that provides integrated, science-driven services to help biopharmaceutical companies bring new drugs and products to market. Operating primarily in the pharmaceutical and biotechnology sectors, Frontage offers a wide range of services including drug discovery, development, and laboratory testing. The company's core services focus on bioanalysis, preclinical and clinical studies, and chemistry, manufacturing, and controls (CMC) services, aiming to deliver comprehensive support throughout the drug development process.
Technical Analysis
Genscript Biotech
―
Shanghai Junshi Biosciences Co., Ltd. Class H
―
Simcere Pharmaceutical Group Limited
―
Shanghai Henlius Biotech, Inc. Class H
―
Shandong Boan Biotechnology Company., Limited. Class H
―
Options Prices
Currently, No data available
---